Cell line name NCC-MFS4-C1
Accession CVCL_B3RL
Resource Identification Initiative To cite this cell line use: NCC-MFS4-C1 (RRID:CVCL_B3RL)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: ~64 hours (PubMed=34383271).
Omics: SNP array analysis.
Derived from site: In situ; Lower leg, hypodermis; UBERON=UBERON_0003823+UBERON_0002072.
Sequence variations
Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Unspecified (PubMed=34383271).
Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Unspecified (PubMed=34383271).
Disease Myxofibrosarcoma (NCIt: C6496)
Myxofibrosarcoma (ORDO: Orphanet_79105)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 65Y
Category Cancer cell line
STR profile

Source(s): PubMed=34383271


Amelogenin X
D5S818 12
D7S820 11,12
D13S317 8
D16S539 10
D21S11 29,32.2
TH01 6
TPOX 8,12
vWA 14,17

PubMed=34383271; DOI=10.1007/s13577-021-00589-x
Yoshimatsu Y., Noguchi R., Tsuchiya R., Sin Y., Ono T., Sugaya J., Iwata S., Yoshida A., Kawai A., Kondo T.
Establishment and characterization of NCC-MFS4-C1: a novel patient-derived cell line of myxofibrosarcoma.
Hum. Cell 34:1911-1918(2021)

Encyclopedic resources Wikidata; Q110433086

Additional information

User Category

Academia/non-profit organization, For-profit organization


There are no reviews yet.

Be the first to review “NCC-MFS4-C1”

Your email address will not be published. Required fields are marked *